How to Treat Hematospermia

Haematospermia—the presence of blood in the ejaculate—is a condition that often alarms patients but is typically benign and self-limiting. While it can occur at any age, it is most commonly observed in men between 40 and 60 years old. The underlying causes range from minor, transient inflammation (such as prostatitis or seminal vesiculitis) to more serious conditions including genitourinary malignancies, infections like tuberculosis or sexually transmitted infections, structural abnormalities, or post-procedural complications following urological interventions (e.g., transrectal prostate biopsy or vasectomy).

Initial evaluation should include a thorough history—focusing on duration, frequency, associated symptoms (e.g., dysuria, pelvic pain, hematuria, fever), recent instrumentation or trauma—and a targeted physical examination, including digital rectal exam to assess for prostate or seminal vesicle abnormalities. Urinalysis, urine culture, and semen analysis are routinely recommended. In men over 40 or those with persistent haematospermia (>4 weeks), elevated PSA, or concerning clinical features, further imaging—such as transrectal ultrasound or multiparametric MRI—is warranted to exclude malignancy or structural pathology.

Management is primarily cause-directed. Most cases resolve spontaneously within several weeks without intervention. For suspected infectious causes, empiric antimicrobial therapy targeting common uropathogens may be appropriate pending culture results. Chronic inflammatory conditions may benefit from alpha-blockers or anti-inflammatory agents. Surgical intervention is rarely indicated but may be considered for identifiable, treatable lesions—such as obstructive cysts or vascular malformations—identified on imaging.

Patient reassurance is a cornerstone of care: the vast majority of haematospermia cases are idiopathic or linked to benign, self-resolving processes. However, clinicians must maintain vigilance for red-flag features—including unilateral scrotal pain, palpable masses, systemic symptoms, or recurrent episodes—to ensure timely diagnosis and management of potentially serious underlying disease.